| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/03/2009 | EP2064177A2 Protease inhibitors |
| 06/03/2009 | CN101448810A Production of phthalic anhydride by gas phase oxidation of o-xylol |
| 06/03/2009 | CN101448809A Production of phthalic anhydride by gas phase oxidation of o-xylol in a primary and a secondary reactor |
| 06/03/2009 | CN101448808A Method for preventing fumaric acid deposits in the production of maleic acid anhydride |
| 06/03/2009 | CN101448807A Production of 2,5-dihydrofurans and analogous compounds |
| 06/03/2009 | CN101448806A Cyclic hydrofluoroether compounds and processes for their preparation and use |
| 06/03/2009 | CN101448805A Treatment for depressive disorders |
| 06/03/2009 | CN101445497A Method for synthesizing benzofuranol by catalyzing with basic aluminum carboxylate |
| 06/03/2009 | CN100494188C Carabrane type sesquiterpene lactone compound with sterilization activity separated from Carpesium macrocephalum Franch.et Sav and its application |
| 06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2009 | WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/28/2009 | WO2009030510A3 5-(substituted methyl) 2-methylfuran |
| 05/28/2009 | WO2009030507A3 Hydroxymethylfurfural ethers from sugars and higher alcohols |
| 05/28/2009 | WO2009030506A3 Hydroxymethylfurfural ethers from sugars or hmf and branched alcohols |
| 05/28/2009 | WO2009030467A3 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 05/28/2009 | US20090137825 Method of producing a carboxylic alkyl ester |
| 05/28/2009 | US20090137772 Nonlinear optical chromophores with stabilizing substituent and electro-optic devices |
| 05/28/2009 | US20090137664 Saururus cernuus compounds that inhibit cellular responses to hypoxia |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137571 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide;potent openers of the KCNQ family of potassium ion channels; antiepileptic agents;anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders |
| 05/28/2009 | US20090136868 cationic lactone containing perfluorinated sulfonate or sulfonimides with iodonium or sulfonium anions as photoacid generator, a polyhydroxystyrene homo or copolymer and a solvent (propylene glycol/1,2-/, monoalkyl ether, ethyl lactone ); semiconductor, heat exposure, pattern forming; development |
| 05/27/2009 | EP2062901A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same |
| 05/27/2009 | EP2062882A1 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and alignment film |
| 05/27/2009 | EP2062874A1 Process and intermediates for the preparation of aliskiren |
| 05/27/2009 | EP2061778A1 Method for producing cyclic unsaturated compound |
| 05/27/2009 | EP2061755A1 Tricyclic compounds useful in treating iron disorders |
| 05/27/2009 | EP2061753A1 Method for manufacture of escitalopram |
| 05/27/2009 | EP2061751A1 Nitrate esters of aminoalcohols |
| 05/27/2009 | EP1694627B1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 05/27/2009 | CN201246966Y Benzoic anhydride and maleic anhydride sections cooling apparatus |
| 05/27/2009 | CN101440079A Process for the preparation of racemic citalopram and/or S- or R-citalopram |
| 05/27/2009 | CN101440078A 2,3-disubstituted benzofuran compounds and preparation thereof |
| 05/27/2009 | CN101440077A Process for synthesizing 2-(1'(Z) alkenyl iodo-alkyl) tetrahydrofuran |
| 05/27/2009 | CN101440076A Process for synthesizing optical activity 2-(1'(Z) alkenyl iodo-alkyl) tetrahydrofuran |
| 05/27/2009 | CN101440026A Method of producing hodge' carbonyls and oligomeric lignin |
| 05/27/2009 | CN101439039A Fortifier |
| 05/27/2009 | CN100491379C Method for extracting curcumcnol, antifertility drug with curcumenol as main active ingredient for rats |
| 05/27/2009 | CN100491366C Use of wogonin as medicament for treatment of anxiety |
| 05/27/2009 | CN100491364C Sesquiterplactone in dandelion and its use of resisting Gram's positive bacteria |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/27/2009 | CN100491325C High activity thermo-crosslinking acid decomposable compound and its synthesis process |
| 05/27/2009 | CN100491323C Biaryloxymethylarenecarboxylic acids compound |
| 05/27/2009 | CN100491316C Novel compounds, their preparation and use |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538234 Preparation of Optically active 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4, 9-diones having anticancer activities |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009064684A1 Substituted heterocyclic ethers and their use in cns disorders |
| 05/22/2009 | WO2009064515A1 Terephthalic acid composition and process for the production thereof |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063833A1 Benzochrysene derivative and organic electroluminescent device using the same |
| 05/22/2009 | WO2009062703A1 Mycophenolic acid immunogens and antibodies |
| 05/22/2009 | WO2008043567A8 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | CA2705425A1 Terephthalic acid composition and process for the production thereof |
| 05/22/2009 | CA2701339A1 Mycophenolic acid immunogens and antibodies |
| 05/21/2009 | US20090131691 Production of 2,5-Dihydrofurans and Analogous Compounds |
| 05/21/2009 | US20090131690 Method for the synthesis of 5-alkoxymethyl furfural ethers and their use |
| 05/21/2009 | US20090131688 Method for the synthesis of 4-benzofuran-carboxylic acid |
| 05/21/2009 | US20090131673 Electroluminescent Device |
| 05/21/2009 | US20090131510 Compounds with activity at estrogen receptors |
| 05/21/2009 | US20090131498 Enantioselective Synthesis of Merrilactone and Its Analogs |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090131378 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof |
| 05/21/2009 | US20090131300 Regiospecific Furan Compounds and Their Use in Fragrances |
| 05/21/2009 | US20090126932 Reversible polymeric gelation for oilfield applications |
| 05/20/2009 | EP2060567A1 Regiospecific furan compounds and their use in fragrances |
| 05/20/2009 | EP2059265A2 Malodor counteracting compositions and method for their use |
| 05/20/2009 | EP1888058B1 Inhibitors of soluble adenylate cyclase |
| 05/20/2009 | CN101434591A Preparation and detection method of salvianolic acid B from salvia miltiorrhiza |
| 05/20/2009 | CN101434590A Preparation of salvianolic acid B pure product |
| 05/20/2009 | CN101434589A Method for preparing 5-hydroxymethyl furfural from fructose source biomass |
| 05/20/2009 | CN101434588A Method for preparing 2,5-dimethyl furan from 5-hydroxymethyl furfural |
| 05/20/2009 | CN101434517A Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/20/2009 | CN100488940C Oxalate for preparing ambrox or releasing ambrox in cigarette smoke and its use |
| 05/19/2009 | US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis |
| 05/19/2009 | US7534812 compounds are valuable intermediate products for the synthesis ofsubstances like gliquidone or glurenorm; diabetes; improved process for industrial scale preparation; saponification, hydrolysis |
| 05/19/2009 | US7534475 For preparation of thin phase retarder, such as wide-ranged polarization plate, which gives inverse wavelength distribution |
| 05/19/2009 | CA2407929C Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 05/19/2009 | CA2387268C Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives |
| 05/19/2009 | CA2317036C Novel optically active aminopentane derivatives |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009061744A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/14/2009 | WO2009061167A1 An improved process to produce high surface area nanoparticle vanadium phosphorus oxide catalyst and product derives thereof |
| 05/14/2009 | WO2009021740A3 Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments |
| 05/14/2009 | WO2008137816A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2009 | US20090124687 Benzofuran Compound and Pharmaceutical Composition Containing the Same |
| 05/14/2009 | US20090124680 Use of prodrug composition containing naphthoquinone-based compound for manufacture of medicament for treatment or prevention of diseases involving metabolic syndrome |
| 05/14/2009 | US20090124669 Structural Analogues of Avenanthramides, Their Use in Compositions Useful in the Treatment of Dermatological Disorders |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124613 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 05/14/2009 | CA2704473A1 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/13/2009 | EP2057118A2 Compounds for treatment of proliferative disorders |
| 05/13/2009 | EP2057117A2 Compounds for treating proliferative disorders |
| 05/13/2009 | EP2056817A1 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system |